Yahoo · Nov 12, 2026
A $19 Billion Fund Bought These 3 Stocks
Key TakeawaysVeritas Asset Management, a firm that manages $19. 1 billion, added to Intercontinental Exchange, Vulcan Materials and Stryker in the third quarter, its new 13F shows.

NYSE · SYK
Healthcare · Medical - Devices
$318.15
Down-$5.07 (-1.59%)
Updated Nov 20, 2026, 1:25 AM
SID Score
5.6/10
Composite research score
Smart Money
35/100
Bearish
Price performance · SYK
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 18, 2026
SYK closed at $318.15 after 20 trading sessions, up 3.60% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | $313.88 | $321.83 | $313.36 | $318.15 | 3.28M |
| Nov 17, 2026 | $309.12 | $319.33 | $308.00 | $317.54 | 4.57M |
| Nov 16, 2026 | $314.34 | $315.50 | $309.2401 | $310.72 | 2.48M |
| Nov 13, 2026 | $316.07 | $316.07 | $306.545 | $309.64 | 3.25M |
| Nov 12, 2026 | $321.42 | $323.61 | $311.8101 | $312.39 | 2.44M |
| Nov 11, 2026 | $319.23 | $320.70 | $315.37 | $318.79 | 3.22M |
| Nov 10, 2026 | $324.07 | $324.76 | $317.87 | $324.29 | 2.64M |
| Nov 9, 2026 | $328.88 | $330.33 | $324.66 | $325.73 | 2.55M |
| Nov 6, 2026 | $324.41 | $328.015 | $322.56 | $325.87 | 3.78M |
| Nov 5, 2026 | $342.45 | $349.48 | $329.855 | $335.08 | 4.46M |
| Nov 4, 2026 | $327.94 | $342.65 | $322.00 | $339.65 | 6.49M |
| Nov 3, 2026 | $307.12 | $312.74 | $306.41 | $310.55 | 2.59M |
| Nov 2, 2026 | $294.31 | $307.895 | $293.00 | $306.81 | 3.74M |
| Oct 30, 2026 | $287.97 | $299.17 | $282.18 | $291.86 | 6.44M |
| Oct 29, 2026 | $306.99 | $312.795 | $305.87 | $311.75 | 3.08M |
| Oct 28, 2026 | $297.52 | $305.29 | $297.00 | $304.00 | 2.33M |
| Oct 27, 2026 | $304.06 | $305.62 | $298.86 | $301.42 | 2.27M |
| Oct 26, 2026 | $305.43 | $307.47 | $301.78 | $306.13 | 1.89M |
| Oct 23, 2026 | $305.01 | $309.57 | $305.00 | $307.15 | 1.98M |
| Oct 22, 2026 | $299.80 | $309.68 | $299.36 | $307.08 | 2.8M |
The latest Smart Investors Daily articles mentioning SYK.
Company
Market Activity
Research & News
SYK research
Company profile and research snapshot.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 18, 2026 | BTIG | Buy | — |
| Nov 9, 2026 | Piper Sandler | Overweight | — |
| Nov 2, 2026 | Stifel | Buy | — |
| Nov 2, 2026 | Truist Securities | Hold | — |
| Oct 30, 2026 | Citigroup | Buy | — |
No generated briefing is available yet.
Yahoo · Nov 12, 2026
Key TakeawaysVeritas Asset Management, a firm that manages $19. 1 billion, added to Intercontinental Exchange, Vulcan Materials and Stryker in the third quarter, its new 13F shows.
Benzinga · Nov 10, 2026
On November 9, a recent SEC filing unveiled that Ronda E Stryker, Director at Stryker (NYSE:SYK) made an insider sell. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed
Fintel · Nov 10, 2026
Benzinga · Nov 9, 2026
Piper Sandler analyst Matt O'Brien maintains Stryker (NYSE:SYK) with a Overweight and raises the price target from $325 to $350.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning SYK.